Keyphrases
Wilms Tumor
99%
Children's Oncology Group
53%
Favorable Histology
37%
Tumor
37%
Diffuse Midline Glioma
29%
Group Studies
26%
Breast Cancer Cells
17%
Acetaminophen
17%
Induced Proliferation
17%
Central Nervous System
17%
Oligodendrocyte Precursor Cells
14%
Overexpression
14%
Gene Expression Pattern
14%
Renal Development
13%
MLLT1
13%
Putative Drug Targets
12%
Gene Expression
12%
Prolactin
11%
SIX1
11%
Cell of Origin
10%
Clinical Features
10%
Drosha
10%
DGCR8
10%
Genetic Changes
10%
Breast Cancer
10%
Olig2
10%
Long Non-coding RNA (LncRNA)
10%
H3K27M
10%
Clear Cell Sarcoma of the Kidney
10%
RNA Expression
10%
Genetic Landscape
10%
Pediatric
9%
Renal Tumor
9%
Genome Analysis
9%
Rhabdoid Tumor
9%
TP53 mutation
9%
Mouse Model
9%
Neuroblastoma
9%
Global Gene Expression
9%
Nephrogenic Rest
9%
NF-B
8%
Platelet-derived Growth Factor Receptor (PDGFR)
8%
α-thalassemia
8%
KAP1
8%
Young Adult Women
8%
Chemotherapy Resistance
8%
Estrogen Receptor
8%
Relevant Subset
8%
Radiosensitivity
8%
C-Myc
8%
Biochemistry, Genetics and Molecular Biology
Wilms' Tumor
100%
Gene Expression
36%
MicroRNA
19%
Genetics
19%
Progenitor Cell
18%
Gene Expression Profiling
18%
Oligodendrocyte Progenitor
15%
Gene Mutation
15%
Prolactin
14%
PDGFA
14%
Mouse Model
14%
Kidney Development
13%
Genomics
13%
SIX1
12%
WT1
11%
Anaplasia
10%
Long Noncoding RNA
10%
Upregulation
9%
ACVR1
8%
Cooperation
8%
SMARCB1
8%
Dimerization
8%
Tumor Suppressor Protein
8%
Isoform
8%
Regulatory Network
8%
Differential Gene Expression
8%
Virus Replication
8%
Human Immunodeficiency Virus
8%
Tumor Gene
8%
TCF21
8%
PDGFRA
8%
Transcription Factor EZH2
8%
T Cell
8%
Prohibitin
8%
Platelet-Derived Growth Factor Receptor
8%
Prolactin Receptor
8%
CD8
8%
Homeodomain
8%
Ontogeny
8%
Gene Cluster
8%
Transmembrane Domain
8%
Differentially Expressed Gene
8%
Carcinogenesis
8%
Loss of Heterozygosity
7%
Mesenchymal-Epithelial Transition
6%
Genetically Engineered Mouse Strain
6%
Histone
6%
Cytokine Receptor
5%
P53
5%
Wild Type
5%
Medicine and Dentistry
Wilms' Tumor
90%
Neoplasm
57%
Oncology
53%
Gene Expression
37%
Pediatrics
23%
Ganglioglioma
20%
Kidney Tumour
13%
Gene Mutation
12%
Kidney Development
12%
Gene Expression Profiling
11%
Prevalence
10%
Clinical Feature
10%
Anaplastic Carcinoma
10%
Progenitor Cell
10%
Ganglioneuroblastoma
10%
Rhabdoid Tumor
9%
Solid Malignant Neoplasm
9%
Nestin
9%
Oligodendrocyte
8%
Pontine Glioma
8%
Central Nervous System
8%
Tumor Gene
8%
Ontogeny
8%
Mediator
8%
Protein Tyrosine Kinase
8%
Prohibitin
8%
Fibrosarcoma
8%
Stromal Tumor
8%
Long Untranslated RNA
8%
Transcription Factor EZH2
8%
Polo Like Kinase 4
8%
Exon
8%
Leukemia
8%
Tumor Suppressor Protein
8%
Heterozygosity
7%
microRNA
7%
Carcinogenesis
6%
GAB2
5%
Mesenchymal-Epithelial Transition
5%
Protein P53
5%
Mesoblastic Nephroma
5%
Pediatric Cancer
5%
Platelet Derived Growth Factor
5%
